United States · FDA National Drug Code directory
Nystatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0121-0810_d57cde69-0eb9-180d-e053-2995a90a33aa
- Product NDC
- 0121-0810
- Form
- SUSPENSION
- Composition / generic term
- NYSTATIN
- Labeler
- Pharmaceutical Associates, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160201
- Source listing expiry
- 20261231
Source-listed ingredients
- NYSTATIN — 100000 [USP'U]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 60 mL in 1 BOTTLE, DROPPER (0121-0810-02) · 0121-0810-02
- 473 mL in 1 BOTTLE (0121-0810-16) · 0121-0810-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →